Booklet 10: Education sector responses to the use of alcohol, tobacco and drugs
As we welcome in the New Year it seems an ideal time to take stock and present the key points from the 2016 European Drug Report (EDR), the European Monitoring Centre for Drug and Addiction’s (EMCDDA) annual review of the European drug situation.
It includes analyses of trends, situational information, and data from individual countries.
Luego de muchos años de investigación en el área de publicidad del alcohol, incluye varias publicaciones en revistas científicas y libros, un grupo de investigadores se fue formando en Brasil y nos encontramos con el tema llamado “responsabilidad social” de las empresas de alcohol. Este fenómeno se volvió cada vez más frecuente en Brasil a partir de los años 2000.
New figures from NHS England present the most recent smoking statistics nationwide.
The report offers a general image of smoking habits and related health issues across England.
It includes information on:
The Canadian Centre on Substance Use and Addiction (CCSA) has recently teamed up with the National Recovery Advisory Committee to produce the first Canadian survey of people in recovery from drug addiction and/or alcoholism.
The findings reached will be particularly useful to healthcare providers, policy-makers and members of the public and help to foster a social environment that supports and celebrates the principles of recovery.
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has recently released its European Drug Report for 2017. The document offers an overview of the drug situation across the continent. It covers drug supply and use as well as public health issues and drug policy/responses.
A key objective of Facing Addiction’s Action Agenda is to spread the awareness and adoption of youth prevention activities in your communities, examples of which include evidence-based prevention programming highlighted in the 2016 U.S.
Key studies on the role of management in the treatment of problem drinking in criminal justice settings and/or to safeguard the community. Just as for practitioners, for managers the challenge is to extract therapeutic benefit out of a coercive, punishment-oriented context.
The World Health Organization has released a series of briefings on violence prevention. Of particular interest is Chapter 3: Preventing Violence by Reducing Availability and Harmful Use of Alcohol.
The United Nations Office on Drugs and Crime (UNODC) has recently published what the organisation describes as ‘an awareness-raising tool’ aimed at policy-makers, public health officials, local authorities and other stakeholders.
Its intent is to guide more effective practice when dealing with substance use issues in rural settings throughout the world.
‘High-risk drug use and new psychoactive substances’, a new report from the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), takes a look at the emergence of more problematic forms of new psychoactive substance use among a range of demographics.
A cell in the Alcohol Treatment Matrix. In an extreme form, the title poses the dilemma for alcohol treatment staff who may also be (seen as) working for authorities whose main role is to control or punish the ‘client’ or who may be threatening to remove their children.
The final row of the Alcohol Treatment Matrix enters the domain of treatment organised not primarily for the patient, but to safeguard the wider community, encountering what seems a core contradiction depicted on the cover of WHO guidance on alcohol treatment in prison.
A free online training course from the Centers for Disease Control and Prevention (CDC) is now available.
The course addresses the CDC recommendations with respect to the prescription of opioids for chronic pain as well as their treatment implications.
The aim is to improve decision-making and best practice while the overall health and well-being of the patient remains the number one priority.
A recently published White Paper by the Addiction Technology Transfer Centre Newtork (ATTC) starts with the premise that the substance use disorder (SUD) prevention, treatment and recovery workforce is currently undergoing an evolution as a result of changes to health care laws and advances in science.
The Canadian Centre on Substance Abuse (CCSA) has released a new report detailing possible effects of psychoactive prescription drugs while driving. The study was carried out with the effort to inform policy decisions aimed at reducing the injuries as a result of driving impairment.
The following conclusions were reached:
The European Facility Survey Questionnaire (EFSQ) can be used for data collection in any country by those looking to investigate facilities that provide interventions for drug users.
Its aim is to collect information on facilities in respect to treatment systems, administrative characteristics, client usage, staff and quality management and core interventions.
The Talking Route to Recovery
Crack emerged in the late 1980s in Brazil. This emergence was a critical moment for public health; the growing AIDS epidemic led intravenous cocaine users to migrate toward crack use to avoid the use of injection drugs.
Psychosocial interventions are psychological or social interventions used to tackle issues related to substance abuse and behavioural addictions. They can be employed to identify and treat problems, as well as to assist with user reintegration back into wider society.
An updated version of the publication Prevention of Substance Abuse by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is now available in English. Global in scope, it provides an up-to-date review of prevention science and, in its considerations, covers drug abuse – including alcohol and tobacco – as well as behavioural addictions, notably gambling.
The National Institute on Drug Abuse (NIDA) has released a number of new resources.
These are aimed at those working within the criminal justice system and other environments where people in recovery from drug addiction are ready to return to their daily lives.
This is one of 25 cells in the Alcohol Treatment Matrix. The cell discusses key research relating to the roles of psychosocial therapies in local treatment systems.
This document provides evidence for arguments supporting alcohol marketing regulation, and suggests key elements that can be considered by countries in planning, developing, implementing, and evaluating effective regulation. It also provides legislative language that can assist governments in developing or modifying existing laws and implementing monitoring mechanisms.
Latest instalment of online course on alcohol treatment research. See if you agree with influential US researchers that “organizational climate underlies the entire process of innovation adoption”, appreciate the effect of high staff turnover and how to reduce it, and ask yourself: Is my service even ready for change? Is change driven by targets just as good for patients as change motivated by the desire to improve their lives?
The National Institute on Drug Abuse (NIDA) has published an extended overview detailing the impact of certain drugs on brain functioning, as well as the most common experimental methods used in related research.
Neuroscientists primarily focus on two issues:
One of our selection of hot topics, analyses of important issues which sometimes generate heated debate. Programmes distributing the opiate overdose antidote naloxone have become the great new hope for curbing the rise in drug-related deaths, but England is lagging behind the rest of the UK. Continue reading...
This manual is designed to teach cultural competence concepts, values, and strategies for engagement and treatment with Hispanics and Latinos with substance use disorders (SUD).
Fortnightly instalment of online course on alcohol treatment research starts with a study which concluded that “leaders have a cascading impact on their staff in ways other than through mandate”. Findings that post-training ‘coaching’ is needed to produce competent therapists mean management is critical to staff development and client progress.
Robust messages for the government from the UK’s official drug policy advisers:
Please note that the content provided within the Knowledge Share section of the ISSUP website does not necessarily reflect the views of ISSUP. It is provided to inform discussion of key issues in the field with a view to encouraging evidence based, high quality and ethical policy and practice